Analgesic nephropathy natural history, complications and prognosis

Jump to: navigation, search

Analgesic nephropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Analgesic nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

Treatment

Medical Therapy

Future or Investigational Therapies

Case Studies

Case #1

Analgesic nephropathy natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Analgesic nephropathy natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Analgesic nephropathy natural history, complications and prognosis

CDC on Analgesic nephropathy natural history, complications and prognosis

Analgesic nephropathy natural history, complications and prognosis in the news

Blogs on Analgesic nephropathy natural history, complications and prognosis

Directions to Hospitals Treating Analgesic nephropathy

Risk calculators and risk factors for Analgesic nephropathy natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Natural History

Complications

Complications of analgesic nephropathy include pyelonephritis[1] and end-stage kidney disease. Risk factors for poor prognosis include recurrent urinary tract infection and persistently elevated blood pressure. Analgesic nephropathy also appears to increase the risk of developing cancers of the urinary system.[2]

Prognosis

References

  1. Maisonneuve P, Agodoa L, Gellert R; et al. (2000). "Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study". Am. J. Kidney Dis. 35 (1): 157–65. PMID 10620560. Unknown parameter |month= ignored (help)
  2. Blohmé I, Johansson S (1981). "Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy". Kidney Int. 20 (5): 671–5. PMID 7045494. Unknown parameter |month= ignored (help)

Linked-in.jpg